Company presentation
Introducing Cencora
Date: Wednesday 29 November, 2023
Time: 11:48am
Moderator: Herbert Altmann, Head of market access, pricing and reimbursement for PharmaLex (part of Cencora)
Time: 11:48am
Moderator: Herbert Altmann, Head of market access, pricing and reimbursement for PharmaLex (part of Cencora)
Super session
New era in CNS: Rising from the ashes
Date: Thursday 30 November, 2023
Time: 9:00am – 10:00am
Moderator: Dr. Marc-Olivier Bévierre - Life Science Practice Leader, Vintura, part of Cencora
Time: 9:00am – 10:00am
Moderator: Dr. Marc-Olivier Bévierre - Life Science Practice Leader, Vintura, part of Cencora
One expert partner, from global strategy to local implementation
We invest in understanding your situation to provide a tailored solution that empowers global patient access.
Achieve local reimbursement globally
We can help you devise a global strategy and then tailor it to the unique requirements of each market for a coordinated and thoughtful approach to access.
Maximize product value
We go beyond the average partner as experts in both market access strategy and generating the evidence (i.e., we can be both scientific in our thinking and commercial in our approach).
Navigate Health Technology Assessments (HTAs)
We work through the complex HTA processes in different countries, helping our clients’ products meet the specific requirements of each assessment.
Commercialization services
Our team of international healthcare experts offers flexible, integrated capabilities to provide unmatched support worldwide. We use our deep industry knowledge and network of connections to help you to plan and execute your commercialization strategy.
Cell and Gene Therapy
We partner with manufacturers to address the unique challenges of bringing cell and gene therapies to market. We leverage our collective and extensive expertise in specialty logistics, reimbursement and hub services to drive outcomes for our customers.
Digital Therapeutics
As healthcare moves beyond traditional medicine and the digital therapeutics pipeline continues to expand, fulfillment methods need to be easy for patient adoption and provide physicians with visibility into patient use.
The essential guide to drug commercialization
You've invested the time, expertise, and financial resources to develop a therapy that changes patient lives for the better. After all of your hard work and dedication, how can you ensure your product reaches patients? What are the key commercialization considerations for healthcare innovators, established and emerging? Learn how to unlock product potential in this step-by-step guide to making the most of your commercialization investments.
Catch up on the latest edition of HTA Quarterly
Additional thought-leadership on HTA and global market access
Pharma Europe Q&A
Tommy Bramley, Senior Vice President, Market Access and Global Consulting, Cencora, had the privilege of chairing the Market Access and Real World Evidence track at the Pharma Europe 2023 conference. He shared some of his takeaways on the exciting future for this area and why meetings like this matter.
